DIVA Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
DIVA Laboratories has a total shareholder equity of NT$1.0B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.2B and NT$210.9M respectively. DIVA Laboratories's EBIT is NT$92.2M making its interest coverage ratio -22.8. It has cash and short-term investments of NT$536.9M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -22.8x |
| Cash | NT$536.93m |
| Equity | NT$1.03b |
| Total liabilities | NT$210.93m |
| Total assets | NT$1.24b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4153's short term assets (NT$956.4M) exceed its short term liabilities (NT$203.3M).
Long Term Liabilities: 4153's short term assets (NT$956.4M) exceed its long term liabilities (NT$7.6M).
Debt to Equity History and Analysis
Debt Level: 4153 is debt free.
Reducing Debt: 4153 had no debt 5 years ago.
Debt Coverage: 4153 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4153 has no debt, therefore coverage of interest payments is not a concern.